BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase (Q36026747)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase |
scientific article |
Statements
1 reference
BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase (English)
1 reference
T P Hughes
1 reference
A Quintás-Cardama
1 reference
M J Mauro
1 reference
D-W Kim
1 reference
J H Lipton
1 reference
M B Bradley-Garelik
1 reference
J Ukropec
1 reference
29 June 2015
1 reference
1 reference
1832-1838
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference